海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300584 海辰药业

交易中 12-19 10:47:51

{"stockData":{"symbol":"300584","market":"SZ","secType":"STK","nameCN":"海辰药业","latestPrice":49.1,"timestamp":1766112471000,"preClose":48.68,"halted":0,"volume":1267000,"delay":0,"changeRate":0.0086,"floatShares":82110700,"shares":120000000,"eps":0.3732,"marketStatus":"交易中","change":0.42,"latestTime":"12-19 10:47:51","open":48.57,"high":49.66,"low":48.51,"amount":62251100,"amplitude":0.0236,"askPrice":49.1,"askSize":12,"bidPrice":49.09,"bidSize":14,"shortable":0,"etf":0,"ttmEps":0.3732,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1766115000000},"marketStatusCode":2,"adr":0,"adjPreClose":48.68,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":53.55,"lowLimit":43.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":120000000,"isCdr":false,"pbRate":5.6,"roa":"--","peRate":131.564845,"roe":"3.16%","epsLYR":0.3351,"committee":-0.272727,"marketValue":5892000000,"turnoverRate":0.0154,"status":0,"floatMarketCap":4032000000},"requestUrl":"/m/hq/s/300584/wiki","defaultTab":"wiki","newsList":[{"id":"2589591338","title":"海辰药业(300584.SZ)：公司注射用盐酸兰地洛尔被纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589591338","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589591338?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:06","pubTimestamp":1765181211,"startTime":"0","endTime":"0","summary":"海辰药业(300584.SZ)公告，据国家医保局、人力资源社会保障部发布《关于印发&lt;国家基本医疗保险、生育保险和工伤保险药品目录&gt;以及&lt;商业健康保险创新药品目录&gt;(2025年)的通知》，公司注射用盐酸兰地洛尔(50mg)续约成功,注射用盐酸兰地洛尔(150mg)首次纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2025年)》。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2589338651","title":"海辰药业：截至2025年11月28日股东总户数25,768户","url":"https://stock-news.laohu8.com/highlight/detail?id=2589338651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589338651?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:00","pubTimestamp":1765180825,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月08日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年11月30日，公司股东人数总数是多少？谢谢！海辰药业回复：尊敬的投资者您好，截止至2025年11月28日，公司股东总户数25,768户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800013883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2588095747","title":"海辰药业：截至11月20日股东数为25776户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588095747","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588095747?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:27","pubTimestamp":1764577626,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2025年11月20日，公司股东人数总数是多少？谢谢！海辰药业回复：尊敬的投资者您好，截至11月20日，公司股东数为25776户。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100016888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2588747064","title":"海辰药业：与四川赛科动力合作开发粘结剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747064","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747064?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:25","pubTimestamp":1764577524,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司和四川赛科动力合作开发的粘结剂主要是为了解决固态电解质和正负极之间的界面接触问题吗？固固接触问题被认为固态电池技术的关键难题，目前公司粘结剂技术成果进展如何？海辰药业回复：尊敬的投资者您好，公司与四川赛科动力合作开发的粘结剂主要解决固固接触及相关副反应问题，目前正在小试产品定型阶段。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100016702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2588747100","title":"海辰药业：VC项目进行投产前准备工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747100?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:15","pubTimestamp":1764576916,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司已建6000吨VC和3000吨FEC产线的现状，是否已经投产，何时可以投产？另外，请问贵司硫化物电解质的送样进展？谢谢海辰药业回复：尊敬的投资者您好，公司VC项目正在进行投产前准备工作，硫化锂项目正在进行中试试生产。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2584160738","title":"海辰药业：综合分析相关投产计划安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2584160738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584160738?lang=zh_cn&edition=full","pubTime":"2025-11-18 11:33","pubTimestamp":1763436838,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问市场环境现在如此好，为什么VC产线不投产，是装置有问题吗？请董秘认真回答一下！海辰药业回复：尊敬的投资者您好，公司正在综合分析考虑相关投产计划安排，是否投产受当前市场环境，行业趋势，供需关系，自身产能等因素影响。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800014286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583022625","title":"海辰药业：公司电解液添加剂详细产能可见公司历年定期报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2583022625","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583022625?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:10","pubTimestamp":1763129400,"startTime":"0","endTime":"0","summary":"证券日报网讯海辰药业11月14日在互动平台回答投资者提问时表示，公司电解液添加剂详细产能可见公司历年定期报告，目前主要给国内主要电解液厂供货。固态电池方面主要在硫化锂及粘结剂方面有所布局，详细情况可参见公司定期报告。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxktks4243345.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-14/doc-infxktks4243345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583579075","title":"11月14日海辰药业（300584）龙虎榜数据：游资上海中山东路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579075?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:33","pubTimestamp":1763112814,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月14日公布的交易公开信息显示，海辰药业因日涨幅达到15%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月14日收盘，海辰药业报收于71.9元，上涨19.99%，涨停，换手率26.19%，成交量21.5万手，成交额14.17亿元。上海中山东路等知名游资榜上有名。从龙虎榜公布的三日买卖数据来看，机构合计净买入3558.87万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583572579","title":"海辰药业最新公告：公司目前经营正常不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2583572579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583572579?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:17","pubTimestamp":1763111822,"startTime":"0","endTime":"0","summary":"海辰药业(300584.SZ)公告称，公司股票交易价格连续两个交易日收盘价格涨幅偏离值累计超过30%，属于股票交易异常波动情况。经核实，公司前期披露的信息不存在需要更正、补充之处，近期经营情况正常，内外部经营环境未发生重大变化。公司、控股股东和实际控制人不存在关于本公司的应披露而未披露的重大事项，也不存在处于筹划阶段的重大事项。控股股东和实际控制人在股票交易异常波动期间不存在买卖公司股票的情形。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400027435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583738125","title":"海辰药业(300584.SZ)：甲硫酸新斯的明注射液获得药品注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2583738125","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583738125?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:17","pubTimestamp":1763108239,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海辰药业(300584.SZ)发布公告，公司于近日收到国家药品监督管理局(以下简称“国家药监局”)核准签发的《药品注册证书》，涉及药品：“甲硫酸新斯的明注射液”。甲硫酸新斯的明注射液的获批丰富了公司的产品线，提升了自身的竞争能力，本次获批视同通过一致性评价，该产品的获批对公司未来业绩的提升将产生积极影响。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369289.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"海辰药业(300584.SZ)：甲硫酸新斯的明注射液获得药品注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2583782665","title":"海辰药业：公司VC暂未投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2583782665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583782665?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:09","pubTimestamp":1763107750,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月14日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司VC产能有多少？为何还没有投产？海辰药业回复：尊敬的投资者您好，公司VC暂未投产，将视市场情况决定投产计划。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400024059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2583578265","title":"海辰药业：硫化锂已完成中试线建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2583578265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583578265?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:09","pubTimestamp":1763107750,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业11月14日在投资者关系平台上答复投资者关心的问题。另外公司固态电池硫化锂电解质和粘合剂项目最近进展如何，麻烦董秘解答一下，感谢！公司硫化锂已完成中试线建设，正在试生产；固态电池粘合剂正在小试工艺开发。感谢对海辰药业的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400024061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2583209435","title":"11月14日海辰药业（300584）涨停分析：新能源材料突破、核心产品放量驱动","url":"https://stock-news.laohu8.com/highlight/detail?id=2583209435","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583209435?lang=zh_cn&edition=full","pubTime":"2025-11-14 15:36","pubTimestamp":1763105777,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业11月14日涨停收盘，收盘价71.9元。该股于10点38分涨停，未打开涨停，截止收盘封单资金为5194.42万元，占其流通市值0.88%。11月14日的资金流向数据方面，主力资金净流入3.02亿元，占总成交额21.33%，游资资金净流出2.02亿元，占总成交额14.27%，散户资金净流出1.0亿元，占总成交额7.06%。近5日资金流向一览见下表：该股为医药，创新药，化学原料药概念热股，当日医药概念上涨0.98%，创新药概念上涨0.86%，化学原料药概念上涨0.85%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400019998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000941.SH","160640","399941","159875","300584","BK0239"],"gpt_icon":0},{"id":"2583197559","title":"海辰药业：公司VC和FEC产能暂时未投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2583197559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583197559?lang=zh_cn&edition=full","pubTime":"2025-11-13 15:30","pubTimestamp":1763019057,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月13日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司是否拥有电解液添加剂VC6000吨和FEC3000吨的实际产能？另外赛科动力的固态电池正式投产，与贵司有何合作关系？海辰药业回复：尊敬的投资者您好，公司VC和FEC产能暂时未投产。公司与四川赛科动力科技有限公司共同设立合资公司四川洛辰新材料科技有限公司，切入固态电池粘合剂领域，进一步丰富公司在固态电池材料领域的战略布局。感谢对海辰药业的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300021205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2583155915","title":"海辰药业：截止至2025年11月10日股东总户数为22,133户","url":"https://stock-news.laohu8.com/highlight/detail?id=2583155915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583155915?lang=zh_cn&edition=full","pubTime":"2025-11-13 15:30","pubTimestamp":1763019057,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月13日在投资者关系平台上答复投资者关心的问题。投资者提问：你好请问一下，截止11月10日最新的股东人数是多少？望告知一下，万分感谢海辰药业回复：尊敬的投资者您好，截止至2025年11月10日，公司股东总户数为22,133户。感谢对海辰药业的关注!以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300021208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2583853558","title":"“吃药”行情归来？4600亿巨头成功扭亏，港A创新药全线沸腾","url":"https://stock-news.laohu8.com/highlight/detail?id=2583853558","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583853558?lang=zh_cn&edition=full","pubTime":"2025-11-13 14:18","pubTimestamp":1763014725,"startTime":"0","endTime":"0","summary":"机构：中国创新药产业已进入2.0时代","market":"hk","thumbnail":"https://static.tigerbbs.com/a9cdeabfc0af4ed4ad7c24a7818b7af3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a9cdeabfc0af4ed4ad7c24a7818b7af3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f6068c36e82c4ed544af336a63a9d021","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3190454","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1191","IE00BZ08YT58.USD","BK0239","300584","300497","BK1141","BK0201","BK1161","06978","BK1589","002864","BK1521","HK0000165453.HKD","688382","IE00BZ08YR35.GBP","02268","01672","01177","SG9999014674.SGD","LU2488822045.USD","BK1515","BK1574","IE00BZ08YS42.EUR"],"gpt_icon":1},{"id":"2582432648","title":"海辰药业：公司暂未有出口国外药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2582432648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582432648?lang=zh_cn&edition=full","pubTime":"2025-11-10 11:36","pubTimestamp":1762745783,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月10日在投资者关系平台上答复投资者关心的问题。投资者提问：最近疫情严重，公司是否出口国外药物海辰药业回复：尊敬的投资者您好，公司暂未有出口国外药物，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000009864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2580273680","title":"海辰药业：截至10月31日股东数为22781户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580273680?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:03","pubTimestamp":1762218200,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)11月03日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问截止10月31日最新的股东人数是多少？望告知一下，万分感谢海辰药业回复：尊敬的投资者您好，截至10月31日，公司股东数为22781户，感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400006652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0},{"id":"2578762153","title":"股市必读：海辰药业（300584）10月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2578762153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578762153?lang=zh_cn&edition=full","pubTime":"2025-10-28 01:15","pubTimestamp":1761585318,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，海辰药业报收于56.55元，上涨6.28%，换手率10.91%，成交量8.96万手，成交额5.02亿元。董秘最新回复投资者： 中报显示公司固态电解质中试线预计三季度投产，现在已经是四季度，请问固态电解质进展如何？感谢对海辰药业的关注！当日关注点来自交易信息汇总：10月27日主力资金净流入2807.78万元，显示主力对个股呈积极介入态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800001519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300584","BK0239"],"gpt_icon":0},{"id":"2578698407","title":"海辰药业：硫化锂项目已按计划完成中试线建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2578698407","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578698407?lang=zh_cn&edition=full","pubTime":"2025-10-27 11:36","pubTimestamp":1761536199,"startTime":"0","endTime":"0","summary":"证券之星消息，海辰药业(300584)10月27日在投资者关系平台上答复投资者关心的问题。投资者提问：中报显示公司固态电解质中试线预计三季度投产，现在已经是四季度，请问固态电解质进展如何？海辰药业回复：尊敬的投资者您好，公司硫化锂项目已按计划完成中试线建设，正在有序推进试生产工作。感谢对海辰药业的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700011181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300584"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766112473829,"stockEarnings":[{"period":"1week","weight":-0.0305},{"period":"1month","weight":-0.2297},{"period":"3month","weight":-0.1948},{"period":"6month","weight":0.2638},{"period":"1year","weight":1.2644},{"period":"ytd","weight":1.4216}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.0147},{"period":"6month","weight":0.1537},{"period":"1year","weight":0.1461},{"period":"ytd","weight":0.1565}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京海辰药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25768人(较上一季度减少0.03%)","perCapita":"3186股","listingDate":"2017-01-12","address":"江苏省南京市栖霞区经济技术开发区恒发路1号","registeredCapital":"12000万元","survey":"　　南京海辰药业股份有限公司的主营业务是化学制剂、原料药及中间体的研发、生产、销售。公司的主要产品是心脑血管类、抗感染类、利尿类、消化类、免疫调节类、其他类。","listedPrice":11.11},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海辰药业,300584,海辰药业股票,海辰药业股票老虎,海辰药业股票老虎国际,海辰药业行情,海辰药业股票行情,海辰药业股价,海辰药业股市,海辰药业股票价格,海辰药业股票交易,海辰药业股票购买,海辰药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海辰药业(300584)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海辰药业(300584)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}